PHARMASCROLL
enquiry@pharmascroll.com Mail Us
  • Home
  • About Us
    • Mission and Vision
    • Our Team
    • Why PharmaScroll
  • Business Intelligence
    • TreasureTell
  • Social Media Analytics
    • SocialBI
  • Market Research Services
  • Newsroom
    • Blog
    • Podcast
    • Press Release
    • Recent News
      • Neuroscience
        • Migraine
        • Multiple Sclerosis
        • Alzheimer’s
        • Parkinson’s
        • Epilepsy
        • Schizophrenia
        • Depression
        • ADHD
      • Respiratory
        • COPD
        • Asthma
        • Pulmonary Fibrosis
        • Cystic fibrosis
        • Rhinitis
      • Oncology
      • Diabetes
  • Careers
  • Contact Us
PHARMASCROLL
  • Home
  • About Us
    • Mission and Vision
    • Our Team
    • Why PharmaScroll
  • Business Intelligence
    • TreasureTell
  • Social Media Analytics
    • SocialBI
  • Market Research Services
  • Newsroom
    • Blog
    • Podcast
    • Press Release
    • Recent News
      • Neuroscience
        • Migraine
        • Multiple Sclerosis
        • Alzheimer’s
        • Parkinson’s
        • Epilepsy
        • Schizophrenia
        • Depression
        • ADHD
      • Respiratory
        • COPD
        • Asthma
        • Pulmonary Fibrosis
        • Cystic fibrosis
        • Rhinitis
      • Oncology
      • Diabetes
  • Careers
  • Contact Us
enquiry@pharmascroll.com Mail Us
HomeNewsNeuroscienceMultiple Sclerosis
  • Recent MS survey, sponsored by Celgene, highlights useful patient insights

    • October 16, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more
  • Further evidence generated for Neurofilament light chain as MS biomarker

    • September 7, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more
  • Ibudilast shows benefits on slowing brain shrinkage in the latest trial results

    • September 6, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more
  • New form of Multiple Sclerosis, MCMS, identified by investigators

    • August 23, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more
  • Multiple Sclerosis patients taking IV treatment mostly satisfied, claims study

    • August 20, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more
  • TG Therapeutics completes Enrollment for Ublituximab in MS trial

    • August 12, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more
  • Botox shows efficacy in Multiple Sclerosis urinary symptoms

    • August 10, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more
  • Sanofi launches multiple sclerosis drug Aubagio in India

    • August 7, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more
  • New Biomarkers identified for Progressive Multiple Sclerosis

    • July 8, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more
  • Pre-clinical data for EHP-101 in Multiple Sclerosis, presented by Emerald

    • July 5, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more
  • 1
  • 2
  • 3
  • …
  • 7
Recent Posts
  • Unlocking the Benefits of SocialBI for Patient Engagement
  • Predictive Analytics in Healthcare
  • Business Intelligence and Analytics in the Pharma Industry
  • Role of Patient Insights in Building Strong Healthcare
  • Social Media Analytics in Healthcare

Contact Us

  • Indian Address: PharmaScroll Research and Consulting Private Limited, 91 Springboard, 4th floor, F948+W7, Laxmi Cyber City, Whitefields, Hyderabad, Telangana 500081
  • US address: 12 Self Ct, Wallingford CT 06492
  • +919311760222
  • enquiry@pharmascroll.com

Recent Tweets

Could not authenticate you.

Recent Posts

  • Unlocking the Benefits of SocialBI for Patient Engagement
  • Predictive Analytics in Healthcare
  • Business Intelligence and Analytics in the Pharma Industry

News Letter

© 2025 Copyright. All rights reserved